Global Rubidium Market Outlook to 2026

Rubidium is a very soft, highly reactive (among the highest in the periodic table), silvery-white metal in the alkali metal group. It is the first element in the group that’s denser than water and sinks. Rubidium metal is easily vaporized and has a convenient spectral absorption range, making it a frequent target for laser manipulation of atoms. With a slightly higher melting point than normal human body temperature, rubidium can be found in a molten/ liquid state under slightly warmer conditions.

According to BlueQuark Research & Consulting, the global rubidium market is expected to witness growth at a considerable rate during the forecast period. The major factors responsible for the global rubidium market's growth would be growing biomedical research-oriented applications and increasing demand in the making of specialty glasses. Rubidium Chloride and Rubidium Carbonate are the key compounds in the respective sectors mentioned above. Atomic resonance-frequency-reference oscillators, photovoltaic cells, and fireworks are a few other products with rubidium’s applications, guiding the market. However, availability and high cost are two challenges besides transportation and storage-related safety issues that restrain the rubidium market's growth.

North America is expected to be the largest market for global rubidium due to its existing market position in the electronics and optics sectors. The growth here is likely to be faster than that in other regions due to the region’s knack for high-tech gadgets and innovations. Rubidium, a rather lesser-known element, has scope for applications in quite a diverse range of products or processes, including areas such as quantum physics. With each passing year, rubidium adds another feather to its cap of applications.

The global rubidium market is consolidated. Major players in the market were found to be American Elements, Lithium Australia, LANHIT, Inorganic Ventures, and Montero Mining and Exploration, among others.

Bracco Diagnostics Inc., the U.S subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, announced on 16 October 2020 the FDA approval of its new CardioGen-82 infusion system to enhance automation, efficiency, and simplicity in cardiac position emission tomography (PET) myocardial perfusion imaging (MPI). This next-generation infusion system model will replace the company's current infusion system.

CARDIOGEN-82® (Rubidium Rb 82 Generator) is a closed system used to produce rubidium Rb 82 chloride injection for intravenous administration. Rubidium Rb 82 chloride injection is a radioactive diagnostic agent indicated for PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

GlobalRubidium Market report provides deep insights into the current and future state of the rubidium market across various regions. The study comprehensively analyzes the rubidium market by segmenting based on type (Rubidium Chloride, Rubidium Hydroxide, Rubidium Carbonate, Rubidium Copper Sulfate, Rubidium Silver Iodide, and Others), commercial source (Lepidolite, Pollucite, and Others), application (Specialty Glass, Electronics, Biomedical Research, Pyrotechnics, and Others), and geography (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa). The report examines the market drivers and restraints, along with the impact of Covid-19 on the market’s growth, in detail. The study covers & includes emerging market trends, developments, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with profiles of major companies, including their market shares and projects.